Bioprostethic mitral valve thrombosis due to oral contraceptive drug use and management with ultra-slow thrombolytic therapy

Blood Coagul Fibrinolysis. 2016 Mar;27(2):220-2. doi: 10.1097/MBC.0000000000000420.

Abstract

Prosthetic valve thrombosis is a severe complication, which usually occurs in inadequately anticoagulated patients. Mechanical valve thrombosis is more common than bioprosthetic valve thrombosis (BVT). Oral contraceptive drugs are associated with increased risk of thromboembolism in women. The possible association between oral contraceptive drug use and BVT has never been reported before. We present a case of obstructive BVT occurring after the use of an oral contraceptive drug and successful management with ultra-slow thrombolytic therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Contraceptives, Oral / adverse effects*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Heart Valve Prosthesis*
  • Humans
  • Mitral Valve / pathology
  • Mitral Valve / surgery
  • Thrombolytic Therapy / methods*
  • Thrombosis / chemically induced
  • Thrombosis / drug therapy*
  • Thrombosis / pathology
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Contraceptives, Oral
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator